ProfileGDS4718 / 1552585_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 4% 11% 35% 9% 7% 11% 15% 5% 8% 12% 5% 7% 13% 10% 12% 8% 11% 15% 11% 7% 5% 8% 8% 6% 6% 9% 8% 9% 5% 8% 7% 10% 12% 5% 10% 12% 12% 5% 8% 51% 5% 10% 10% 12% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.543694
GSM549102patient 115, normal, homogenized [OPG study]3.8110611
GSM549104patient 119, normal, homogenized [OPG study]4.7562435
GSM549108patient 138, normal, homogenized [OPG study]3.744389
GSM549119patient 077, normal, homogenized [OPG study]3.675587
GSM549133patient 032, cancer, homogenized [OPG study]3.7910611
GSM549139patient 042, cancer, homogenized [OPG study]3.9500915
GSM549099patient 107, normal, homogenized [OPG study]3.603755
GSM549109patient 139, normal, homogenized [OPG study]3.711058
GSM549110patient 046, normal, homogenized [OPG study]3.8733612
GSM549114patient 063, normal, homogenized [OPG study]3.561835
GSM549122patient 082, normal, homogenized [OPG study]3.671137
GSM549134patient 033, cancer, homogenized [OPG study]3.8827213
GSM549136patient 036, cancer, homogenized [OPG study]3.7494810
GSM549140patient 044, cancer, homogenized [OPG study]3.8290212
GSM549111patient 047, normal, homogenized [OPG study]3.679178
GSM549113patient 057, normal, homogenized [OPG study]3.7725111
GSM549132patient 031, cancer, homogenized [OPG study]3.9527615
GSM549137patient 038, cancer, homogenized [OPG study]3.8252411
GSM549142patient 047, cancer, homogenized [OPG study]3.716917
GSM549100patient 110, normal, homogenized [OPG study]3.583665
GSM549107patient 135, normal, homogenized [OPG study]3.68938
GSM549115patient 068, normal, homogenized [OPG study]3.684788
GSM549116patient 072, normal, homogenized [OPG study]3.610516
GSM549120patient 078, normal, homogenized [OPG study]3.626686
GSM549131patient 030, cancer, homogenized [OPG study]3.712429
GSM549118patient 074, normal, homogenized [OPG study]3.699188
GSM549129patient 027, cancer, homogenized [OPG study]3.772519
GSM549123patient 088, normal, homogenized [OPG study]3.617015
GSM549124patient 006, cancer, homogenized [OPG study]3.713928
GSM549126patient 015, cancer, homogenized [OPG study]3.633567
GSM549128patient 025, cancer, homogenized [OPG study]3.7674210
GSM549103patient 117, normal, homogenized [OPG study]3.8889612
GSM549117patient 073, normal, homogenized [OPG study]3.592975
GSM549138patient 041, cancer, homogenized [OPG study]3.7479910
GSM549141patient 045, cancer, homogenized [OPG study]3.7979812
GSM549130patient 028, cancer, homogenized [OPG study]3.8706812
GSM549101patient 111, normal, homogenized [OPG study]3.59215
GSM549105patient 128, normal, homogenized [OPG study]3.711058
GSM549106patient 134, normal, homogenized [OPG study]5.5082951
GSM549112patient 048, normal, homogenized [OPG study]3.60685
GSM549125patient 011, cancer, homogenized [OPG study]3.7886610
GSM549127patient 024, cancer, homogenized [OPG study]3.7620710
GSM549135patient 035, cancer, homogenized [OPG study]3.7983312